Literature DB >> 18728211

Serum free DNA and COX-2 mRNA expression in peripheral blood for lung cancer detection.

P Ulivi, L Mercatali, W Zoli, D Dell'amore, V Poletti, G L Casoni, E Scarpi, E Flamini, D Amadori, R Silvestrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18728211     DOI： 10.1136/thx.2008.102178

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  9 in total

Review 1.  Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer.

Authors:  Paola Ulivi; Rosella Silvestrini
Journal:  Cell Oncol (Dordr)       Date:  2013-11-01       Impact factor: 6.730

2.  COX-2 overexpression and -8473 T/C polymorphism in 3' UTR in non-small cell lung cancer.

Authors:  Imtiyaz A Bhat; Roohi Rasool; Iqbal Qasim; Khalid Z Masoodi; Shabeer A Paul; Bashir A Bhat; Farooq A Ganaie; Sheikh A Aziz; Zafar A Shah
Journal:  Tumour Biol       Date:  2014-08-12

3.  A systematic review and meta-analysis of circulating cell-free DNA as a diagnostic biomarker for non-small cell lung cancer.

Authors:  Xin He; Yaqian Chi; Jingcui Peng; Wenxia Hu; Cuimin Ding; Bin Li
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 4.  Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Authors:  Marius Ilie; Véronique Hofman; Elodie Long; Olivier Bordone; Eric Selva; Kevin Washetine; Charles Hugo Marquette; Paul Hofman
Journal:  Ann Transl Med       Date:  2014-11

Review 5.  Target therapy in NSCLC patients: Relevant clinical agents and tumour molecular characterisation.

Authors:  Paola Ulivi; Wainer Zoli; Laura Capelli; Elisa Chiadini; Daniele Calistri; Dino Amadori
Journal:  Mol Clin Oncol       Date:  2013-03-29

6.  MMP-7 and fcDNA serum levels in early NSCLC and idiopathic interstitial pneumonia: preliminary study.

Authors:  Paola Ulivi; Gian Luca Casoni; Giovanni Foschi; Emanuela Scarpi; Sara Tomassetti; Micaela Romagnoli; Claudia Ravaglia; Marta Mengozzi; Wainer Zoli; Venerino Poletti
Journal:  Int J Mol Sci       Date:  2013-12-11       Impact factor: 5.923

7.  Association Between COX-2 Polymorphisms and Lung Cancer Risk.

Authors:  Weiwei Wang; Xinyun Fan; Yong Zhang; Yi Yang; Siyuan Yang; Gaofeng Li
Journal:  Med Sci Monit       Date:  2015-12-01

8.  Multiple marker detection in peripheral blood for NSCLC diagnosis.

Authors:  Paola Ulivi; Laura Mercatali; Gian-Luca Casoni; Emanuela Scarpi; Lauro Bucchi; Rosella Silvestrini; Stefano Sanna; Marco Monteverde; Dino Amadori; Venerino Poletti; Wainer Zoli
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

9.  Urine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.

Authors:  Valentina Casadio; Daniele Calistri; Samanta Salvi; Roberta Gunelli; Elisa Carretta; Dino Amadori; Rosella Silvestrini; Wainer Zoli
Journal:  Biomed Res Int       Date:  2013-02-13       Impact factor: 3.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.